Barry James's Form 4 filing
Bio-Rad Laboratories, Inc. (BIO) · filed Sep 3, 2026
- Accession no.
- 0002022345-26-000002
- Filed
- Sep 3, 2026, 5:41 PM ET
- Trade date
- Sep 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Barry JamesCIK 0002022345 | Officer (EVP, President, LSG) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Bio-Rad A Common Stock | MOption exerciseAcquired | +425 | $0.00 | $0 | 934.682 | Direct | |
| Sep 1, 2026 | Bio-Rad A Common Stock | FTax withholdingDisposed | −154 | $380.96 | −$58,667.84 | 780.682 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Bio-Rad A Common Stock | MOption exerciseDisposed | −174 | $0.00 | $0 | 0 | Direct | |
| Sep 1, 2026 | Bio-Rad A Common Stock | MOption exerciseDisposed | −251 | $0.00 | $0 | 251 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.